Oxidative Stress Contributes to Status Epilepticus Associated Mortality

Area of Science:

• Neuroscience
• Toxicology
• Pharmacology

Background:

• Status epilepticus (SE) is a critical condition following nerve agent exposure, leading to high mortality and neurological damage.
• Oxidative stress plays a key role in the pathophysiology of SE and its associated injuries.
• Current treatments for nerve agent-induced SE have limitations in reducing mortality and secondary neurological damage.

Purpose of the Study:

• To investigate the efficacy of the catalytic antioxidant AEOL10150 in mitigating pilocarpine-induced SE.
• To determine if AEOL10150 can reduce mortality, neuronal death, and neuroinflammation associated with SE.
• To evaluate AEOL10150's potential as an adjunct therapy to standard care for nerve agent exposures.

Main Methods:

• Pilocarpine was used to induce status epilepticus (SE) in a rodent model.
• Animals were treated with AEOL10150 in combination with scopolamine and diazepam, or atropine and diazepam (standard care).
• Mortality rates, markers of oxidative stress, neuronal loss, and neuroinflammation were assessed.

Main Results:

• AEOL10150 combined with scopolamine and diazepam significantly reduced mortality compared to scopolamine and diazepam alone.
• Combining AEOL10150 with atropine and diazepam further decreased mortality.
• Both treatment regimens demonstrated significant protection against SE-induced oxidative stress, neuronal damage, and neuroinflammation.

Conclusions:

• Pharmacological targeting of oxidative stress using AEOL10150 is a promising strategy to improve survival following nerve agent-induced SE.
• AEOL10150 can attenuate secondary neurological damage, including neuronal loss and neuroinflammation.
• AEOL10150 represents a potential adjunctive therapy to enhance the effectiveness of current standards of care for nerve agent exposures.